Robust models of SARS-CoV-2 heterogeneity and control
Kory D. Johnson, Annemarie Grass, Daniel Toneian, Mathias Beiglb\"ock,, Jitka Polechov\'a

TL;DR
This paper develops a comprehensive simulation framework to analyze SARS-CoV-2 infection dynamics, considering vaccination, NPIs, variants, and immunity waning, to evaluate control strategies and variant risks.
Contribution
It introduces a hierarchical, dynamic compartment model incorporating super-spreading, immunity waning, and variant risk assessment, advancing COVID-19 modeling capabilities.
Findings
Controller responding to effective reproduction number is more effective.
Risk measure $ ho^V$ varies with vaccination rates and population immunity.
Different population compositions influence variant-specific risks.
Abstract
In light of the continuing emergence of new SARS-CoV-2 variants and vaccines, we create a simulation framework for exploring possible infection trajectories under various scenarios. The situations of primary interest involve the interaction between three components: vaccination campaigns, non-pharmaceutical interventions (NPIs), and the emergence of new SARS-CoV-2 variants. Additionally, immunity waning and vaccine boosters are modeled to account for their growing importance. New infections are generated according to a hierarchical model in which people have a random, individual infectiousness. The model thus includes super-spreading observed in the COVID-19 pandemic. Our simulation functions as a dynamic compartment model in which an individual's history of infection, vaccination, and possible reinfection all play a role in their resistance to further infections. We present a risk…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 epidemiological studies · SARS-CoV-2 and COVID-19 Research · Influenza Virus Research Studies
